Uveitis Trial, Not Yet Recruiting NCT07298174 Sponsor: IRCCS San Raffaele Condition: Uveitis
Back to Uveitis

Uveitis Trial, Not Yet Recruiting

NCT07298174
Not Yet Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be over 18 years old
  • Both men and women are welcome to join
  • You must have a confirmed diagnosis of one of the following eye conditions: age-related macular degeneration, diabetic retinopathy, myopia (short-sightedness), pachychoroid spectrum disease (a group of conditions affecting the layer beneath the retina), inherited retinal dystrophy (an eye condition passed down through families), uveitis (inflammation inside the eye), or dry eye
  • You must have a minimum level of vision — at least being able to see at 1 metre what a person with normal vision can see at 20 metres (confirm with trial site)
  • You must be willing and able to sign a consent form agreeing to take part in the trial

Who may not be able to join:

  • You may not be eligible if you have cloudiness or blockages inside the eye that affect the clarity of vision (such as a dense cataract) (confirm with trial site)
  • You may not be eligible if you have any other eye or general health condition that could permanently affect the results of the study (confirm with trial site)
  • You may not be eligible if you have had surgery on the eye being studied — including cataract removal — within the three months before joining the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +390226432648

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
IRCCS San Raffaele
Registry
ClinicalTrials.gov
Start date
1 January 2026
Est. completion
1 January 2028

Primary endpoints

Retinal vessel density; Conjunctival vessel density

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov